Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
Will Array-Based Molecular Dx Shops Meet Their Goal of Winning FDA Gold in 2006?
At least seven companies with array-based tests in development speculated over the course of 2005 that 2006 would be the year their respective platforms receive FDA clearance. But now that 06 is upon them, the best many can now offer on the fate of their tests is a cautious maybe. Subscribers: click headline for more
New to GenomeWeb? Register quickly here.